122 related articles for article (PubMed ID: 10592709)
1. [Electron microscopy of Candida albicans].
Müller J
Mycoses; 1999; 42 Suppl 1():5-11. PubMed ID: 10592709
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents.
Choukri F; Benderdouche M; Sednaoui P
J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913
[TBL] [Abstract][Full Text] [Related]
4. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of experimental murine vulvovaginal candidiasis with gentian violet.
Bonfim AP; Sakita KM; Faria DR; Arita GS; Rodrigues-Vendramini FA; Capoci IR; Braga AG; Mosca VA; Junior AG; Kioshima ÉS; Bonfim-Mendonça PS; Svidzinski TI
Future Microbiol; 2023 Nov; 18():1137-1146. PubMed ID: 37830930
[No Abstract] [Full Text] [Related]
6. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.
Gunderson SM; Hoffman H; Ernst EJ; Pfaller MA; Klepser ME
Antimicrob Agents Chemother; 2000 Oct; 44(10):2887-90. PubMed ID: 10991881
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
[TBL] [Abstract][Full Text] [Related]
8. Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis.
Zhang X; Li T; Chen X; Wang S; Liu Z
BMC Microbiol; 2018 Oct; 18(1):166. PubMed ID: 30359236
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility and resistance of Candida spp. to hamycin.
Athar MA
Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
[No Abstract] [Full Text] [Related]
10. [Ultrastructural changes in Candida albicans exposed to polyene antibiotics].
Delektorskiĭ VV; Sheklakov ND; Golodova OA
Vestn Dermatol Venerol; 1980 Nov; (11):14-6. PubMed ID: 7003976
[No Abstract] [Full Text] [Related]
11. Fungus-host relationship in candidiasis. A brief review.
Montes LF; Wilborn WH
Arch Dermatol; 1985 Jan; 121(1):119-24. PubMed ID: 3881087
[TBL] [Abstract][Full Text] [Related]
12. [Ultrastructural changes in Candida albicans caused by polyene antibiotics (author's transl)].
Scheklakow ND; Delektorski WW; Golodova OA
Mykosen; 1981 Mar; 24(3):140-52. PubMed ID: 7024797
[No Abstract] [Full Text] [Related]
13. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
Fan SR; Liu XP
Mycoses; 2011 Nov; 54(6):501-5. PubMed ID: 20406393
[TBL] [Abstract][Full Text] [Related]
14. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
Shahid Z; Sobel JD
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
[TBL] [Abstract][Full Text] [Related]
15. The effects of miconazole on the ultrastructure of Candida albicans.
De Nollin S; Borgers M; Van Belle H
Proc R Soc Med; 1977; 70 Suppl 4(Suppl 4):19-23. PubMed ID: 122689
[No Abstract] [Full Text] [Related]
16. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis.
Deva R; Ciccoli R; Kock L; Nigam S
FEMS Microbiol Lett; 2001 Apr; 198(1):37-43. PubMed ID: 11325551
[TBL] [Abstract][Full Text] [Related]
17. [In vitro assessment of the sensitivity of Candida albicans strains isolated from the vagina on basis antimycotics].
Lisiak M; Kłyszejko C; Marcinkowski Z; Gwieździński Z
Ginekol Pol; 2000 Sep; 71(9):971-4. PubMed ID: 11082958
[TBL] [Abstract][Full Text] [Related]
18. Antifungal effects of Lavandula binaludensis and Cuminum cyminum essential oils against Candida albicans strains isolated from patients with recurrent vulvovaginal candidiasis.
Minooeianhaghighi MH; Sepehrian L; Shokri H
J Mycol Med; 2017 Mar; 27(1):65-71. PubMed ID: 27751723
[TBL] [Abstract][Full Text] [Related]
19. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
20. Betamethasone augments the antifungal effect of menadione--towards a novel anti-Candida albicans combination therapy.
Jakab Á; Emri T; Sipos L; Kiss Á; Kovács R; Dombrádi V; Kemény-Beke Á; Balla J; Majoros L; Pócsi I
J Basic Microbiol; 2015 Aug; 55(8):973-81. PubMed ID: 25707543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
